Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.09B |
| 2 |
Apple
AAPL
|
+$871M |
| 3 |
Uber
UBER
|
+$867M |
| 4 |
NVIDIA
NVDA
|
+$687M |
| 5 |
Amazon
AMZN
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$540M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.83% |
| 2 | Financials | 12.77% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
2001
Summit Hotel Properties
INN
$749M
| $17.3M | ﹤0.01% |
2,571,695
+124,352
| +5% | +$765K |
|
|
BELFB
2002
Bel Fuse Inc Class B
BELFB
$3.91B
| $17.3M | ﹤0.01% |
258,770
+7,214
| +3% | +$386K |
|
2003
Bank of N.T. Butterfield & Son
NTB
$2.46B
| $17.3M | ﹤0.01% |
539,780
+11,403
| +2% | +$323K |
|
|
WCN
2004
Waste Connections
WCN
$42.3B
| $17.3M | ﹤0.01% |
112,260
+7,670
| +7% | +$1.05M |
|
|
KREF
2005
KKR Real Estate Finance Trust
KREF
$465M
| $17.2M | ﹤0.01% |
1,299,527
+58,395
| +5% | +$700K |
|
2006
Tompkins Financial
TMP
$1.45B
| $17.2M | ﹤0.01% |
284,996
+10,875
| +4% | +$591K |
|
2007
Methode Electronics
MEI
$499M
| $17.1M | ﹤0.01% |
752,645
+23,677
| +3% | +$554K |
|
2008
Cabaletta Bio
CABA
$439M
| $17.1M | ﹤0.01% |
753,176
+61,304
| +9% | +$1.03M |
|
2009
Levi Strauss
LEVI
$9.48B
| $17.1M | ﹤0.01% |
1,032,726
+47,827
| +5% | +$709K |
|
|
CCRN
2010
DELISTED
Cross Country Healthcare
CCRN
| $17.1M | ﹤0.01% |
754,003
+29,752
| +4% | +$645K |
|
2011
Bank First Corp
BFC
$1.72B
| $17M | ﹤0.01% |
196,418
+10,045
| +5% | +$830K |
|
2012
AdvanSix
ASIX
$542M
| $17M | ﹤0.01% |
566,475
+17,763
| +3% | +$494K |
|
2013
Arcturus Therapeutics
ARCT
$171M
| $17M | ﹤0.01% |
538,265
+26,097
| +5% | +$620K |
|
2014
ImmunityBio
IBRX
$7.49B
| $17M | ﹤0.01% |
3,379,464
+573,281
| +20% | +$1.8M |
|
|
RVNC
2015
DELISTED
Revance Therapeutics, Inc.
RVNC
| $16.9M | ﹤0.01% |
1,924,421
+144,144
| +8% | +$1.18M |
|
2016
Grid Dynamics Holdings
GDYN
$553M
| $16.9M | ﹤0.01% |
1,268,839
+59,039
| +5% | +$720K |
|
|
INVX
2017
Innovex International
INVX
$1.98B
| $16.9M | ﹤0.01% |
726,208
+31,913
| +5% | +$749K |
|
2018
Compañía de Minas Buenaventura
BVN
$7.74B
| $16.8M | ﹤0.01% |
1,112,572
+10,587
| +1% | +$102K |
|
2019
Sturm, Ruger & Co
RGR
$616M
| $16.8M | ﹤0.01% |
369,955
-11,515
| -3% | -$553K |
|
|
CHCT
2020
Community Healthcare Trust
CHCT
$522M
| $16.8M | ﹤0.01% |
630,230
+49,693
| +9% | +$1.37M |
|
|
XRN
2021
Chiron Real Estate Inc
XRN
$511M
| $16.7M | ﹤0.01% |
301,479
+13,320
| +5% | +$646K |
|
2022
Standard Motor Products
SMP
$863M
| $16.7M | ﹤0.01% |
419,743
+12,146
| +3% | +$433K |
|
2023
Regenxbio
RGNX
$638M
| $16.7M | ﹤0.01% |
929,672
+46,526
| +5% | +$820K |
|
2024
B&G Foods
BGS
$290M
| $16.7M | ﹤0.01% |
1,589,104
+115,757
| +8% | +$1.07M |
|
|
RAPT
2025
DELISTED
RAPT Therapeutics
RAPT
| $16.6M | ﹤0.01% |
83,662
+5,051
| +6% | +$625K |
|
Similar funds
Geode Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Geode Capital Management held 4,831 positions worth $956B, up 14% from $840B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q4 2023 filing shows 71 new, 3,576 increased, 304 reduced and 178 closed positions. Its largest new stake was NCR Atleos: 993,462 shares worth $24.2M. The largest sale was Activision Blizzard, an estimated $1.52B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2023 buy was NCR Atleos: 993,462 shares worth $24.2M.
- Geode Capital Management added most to Microsoft in Q4 2023, an estimated $1.09B increase.
- Geode Capital Management's biggest Q4 2023 reduction was Danaher, cutting an estimated $540M.
- Geode Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.52B.
- Geode Capital Management's ten largest holdings make up 26% of its $956B portfolio in Q4 2023.
- Geode Capital Management opened 71 new positions and closed 178 in Q4 2023.
- Geode Capital Management's portfolio value rose 14% quarter-over-quarter to $956B.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.